Scott Dunseth Myers

Filings by Scott Dunseth Myers span 6 companies, the busiest being Cascadian Therapeutics, Inc., Dynavax Technologies Corp and Harpoon Therapeutics, Inc. In total, 30 filings cover trades dated from 28 June 2016 to 10 February 2026.

The open-market record is one-sided, with 11 purchases worth €506k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 14 share grants and 1 option exercise.

A typical purchase (the median) is worth €35k. Of 11 purchases, 1 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

Most recently, on 10 February 2026, the filings show a transaction in Dynavax Technologies Corp. The last insider purchase was made public on 25 August 2025, 425 days ago. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.